1. Home
  2. GIC vs TRVI Comparison

GIC vs TRVI Comparison

Compare GIC & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Industrial Company

GIC

Global Industrial Company

HOLD

Current Price

$31.77

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$11.82

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GIC
TRVI
Founded
1949
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
GIC
TRVI
Price
$31.77
$11.82
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$21.55
AVG Volume (30 Days)
86.2K
1.2M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
3.55%
N/A
EPS Growth
17.09
31.91
EPS
1.85
N/A
Revenue
$1,379,100,000.00
N/A
Revenue This Year
$5.72
N/A
Revenue Next Year
$4.46
N/A
P/E Ratio
$17.04
N/A
Revenue Growth
4.80
N/A
52 Week Low
$20.79
$4.85
52 Week High
$38.53
$14.39

Technical Indicators

Market Signals
Indicator
GIC
TRVI
Relative Strength Index (RSI) 55.05 54.43
Support Level $29.40 $10.07
Resistance Level $32.16 $12.11
Average True Range (ATR) 0.94 0.73
MACD 0.09 0.06
Stochastic Oscillator 85.01 66.23

Price Performance

Historical Comparison
GIC
TRVI

About GIC Global Industrial Company

Global Industrial Co is a value-added industrial distributor. The company distributes a wide range of industrial and maintenance, repair, and operations (MRO) products to customers across North America, including storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, food service and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw materials.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Share on Social Networks: